| 08:30 | 5039 | Low risk of arrhythmic events in dystrophin genotyped patients with dilated cardiomyopathy. | M Diegoli (Pavia, IT) |
|
|
Abstract
|
|
|
|
Slides
|
|
|
| 08:30 | 5040 | Recovery from pregnancy related heart failure: peripartum cardiomyopathy (PPCM). | L Christie (Eugene, US) |
|
|
|
Abstract
|
|
|
| 08:30 | 5041 | Predictors of outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in heart failure with preserved ejection fraction trial (I-PRESERVE). | P E Carson (Washington, US) |
|
|
|
Abstract
|
|
|
|
|
Slides
|
|
|
| 08:30 | 5042 | Diastolic versus systolic left ventricular dysfunction as independent predictors for unfavourable postoperative evolution in patients with aortic regurgitation undergoing aortic valve replacement. | L Iliuta (Bucharest, RO) |
|
|
|
Abstract
|
|
|
| 08:30 | 5043 | State of the Art - Heart failure....inevitably fatal? | J G F Cleland (Kingston upon Hull, GB) |
|
|
|
Slides
|
|
|